Cardiol Therapeutics Inc. (CRDL)
USD 1.14
(1.79%)
USD 1.14
(1.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.78 Million CAD | 40.83% |
| 2022 | -50.33 Million CAD | -10.7% |
| 2021 | -45.47 Million CAD | -120.67% |
| 2020 | -20.6 Million CAD | -51.7% |
| 2019 | -13.58 Million CAD | -83.8% |
| 2018 | -7.39 Million CAD | -365.01% |
| 2017 | -1.58 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -8.4 Million CAD | -4.69% |
| 2024 Q2 | -7.74 Million CAD | 7.9% |
| 2023 Q3 | -7.65 Million CAD | -65.4% |
| 2023 FY | -29.78 Million CAD | 40.83% |
| 2023 Q1 | -7.93 Million CAD | 21.34% |
| 2023 Q2 | -4.62 Million CAD | 41.68% |
| 2023 Q4 | -8.02 Million CAD | -4.87% |
| 2022 FY | -50.33 Million CAD | -10.7% |
| 2022 Q1 | -10.55 Million CAD | 46.96% |
| 2022 Q4 | -10.09 Million CAD | 43.67% |
| 2022 Q3 | -17.91 Million CAD | -52.03% |
| 2022 Q2 | -11.78 Million CAD | -11.69% |
| 2021 Q3 | -10.28 Million CAD | -64.34% |
| 2021 Q4 | -19.89 Million CAD | -93.34% |
| 2021 Q2 | -6.26 Million CAD | 30.7% |
| 2021 FY | -45.47 Million CAD | -120.67% |
| 2021 Q1 | -9.03 Million CAD | 5.89% |
| 2020 FY | -20.6 Million CAD | -51.7% |
| 2020 Q3 | -4.38 Million CAD | -22.89% |
| 2020 Q2 | -3.57 Million CAD | -17.06% |
| 2020 Q1 | -3.04 Million CAD | -0.61% |
| 2020 Q4 | -9.59 Million CAD | -118.79% |
| 2019 Q3 | -3.52 Million CAD | 2.34% |
| 2019 FY | -13.58 Million CAD | -83.8% |
| 2019 Q4 | -3.03 Million CAD | 13.95% |
| 2019 Q1 | -3.42 Million CAD | -6.49% |
| 2019 Q2 | -3.6 Million CAD | -5.39% |
| 2018 Q1 | -532.92 Thousand CAD | 5.69% |
| 2018 Q3 | -2.39 Million CAD | -92.01% |
| 2018 Q4 | -3.21 Million CAD | -34.15% |
| 2018 FY | -7.39 Million CAD | -365.01% |
| 2018 Q2 | -1.24 Million CAD | -134.13% |
| 2017 Q2 | -401 Thousand CAD | 0.0% |
| 2017 FY | -1.58 Million CAD | 0.0% |
| 2017 Q4 | -565.1 Thousand CAD | -11.38% |
| 2017 Q3 | -507.37 Thousand CAD | -26.52% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 80.853% |
| Theratechnologies Inc. | -10.62 Million USD | -180.281% |
| Safety Shot Inc | -12.18 Million USD | -144.461% |
| Cosmos Health Inc. | -21.83 Million USD | -36.435% |
| Cronos Group Inc. | -81.37 Million USD | 63.397% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 114.249% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 23.925% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 337.808% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -744.554% |
| ProPhase Labs, Inc. | -21.61 Million USD | -37.813% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -533.599% |
| Dynavax Technologies Corporation | -37.02 Million USD | 19.56% |
| Radius Health, Inc. | -3.92 Million USD | -658.866% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -1084.212% |
| Alvotech | -354.86 Million USD | 91.606% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -522.438% |
| Alpha Teknova, Inc. | -35.56 Million USD | 16.246% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 81.312% |
| SCYNEXIS, Inc. | 72.66 Million USD | 140.988% |
| Harrow Health, Inc. | 580 Thousand USD | 5235.432% |
| Biofrontera Inc. | -22.67 Million USD | -31.347% |
| DURECT Corporation | -36.88 Million USD | 19.245% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -465.297% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 163.413% |
| OptiNose, Inc. | -22.74 Million USD | -30.937% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 335.794% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -97.229% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -379.574% |
| SIGA Technologies, Inc. | 83.62 Million USD | 135.62% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 419.21% |
| Shineco, Inc. | -17.06 Million USD | -74.533% |
| Phibro Animal Health Corporation | 53.31 Million USD | 155.867% |
| Procaps Group S.A. | 52.32 Million USD | 156.925% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -249.472% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -528.82% |
| Viatris Inc. | 766.2 Million USD | 103.887% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -522.438% |
| Rockwell Medical, Inc. | -6.67 Million USD | -346.559% |
| Incannex Healthcare Limited | -30.04 Million USD | 0.85% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -466.911% |
| Tilray Brands, Inc. | -174.74 Million USD | 82.955% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 117.84% |
| PetIQ, Inc. | 60.01 Million USD | 149.63% |
| Silver Spike Investment Corp. | 7.34 Million USD | 505.791% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 111.871% |
| Journey Medical Corporation | -2.07 Million USD | -1336.831% |
| Alimera Sciences, Inc. | -1.47 Million USD | -1924.847% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -118.732% |
| Assertio Holdings, Inc. | -243.53 Million USD | 87.77% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -405.492% |
| Embecta Corp. | 221.5 Million USD | 113.447% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -48.556% |
| Procaps Group, S.A. | 38.97 Million USD | 176.426% |
| PainReform Ltd. | -9.58 Million USD | -210.784% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 78.393% |
| Hempacco Co., Inc. | -8.81 Million USD | -238.0% |
| Talphera, Inc. | -16.88 Million USD | -76.36% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 133.973% |
| Alvotech | -354.86 Million USD | 91.606% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 108.168% |
| Kamada Ltd. | 10.06 Million USD | 395.961% |
| Indivior PLC | -4 Million USD | -644.638% |
| Currenc Group, Inc. | -6.64 Million USD | -348.186% |
| Evoke Pharma, Inc. | -7.43 Million USD | -300.834% |
| Flora Growth Corp. | -50.35 Million USD | 40.848% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -48.556% |
| Evolus, Inc. | -49.23 Million USD | 39.501% |
| HUTCHMED (China) Limited | 18.37 Million USD | 262.098% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 115.121% |
| Akanda Corp. | -10.05 Million USD | -196.333% |